Neuroimaging of opiate-dependent individuals indicates both altered brain structure and function. Magnetic resonance-based arterial spin labeling has been used to measure noninvasively cerebral blood flow (i.e. perfusion) in alcohol, tobacco and stimulant dependence; only one arterial spin labeling paper in opiate-dependent individuals demonstrated frontal and parietal perfusion deficits. Additional research on regional brain perfusion in opiate dependence and its relationship to cognition and self-regulation (impulsivity, risk taking and decision making) may inform treatment approaches for opiate-dependent individuals. Continuous arterial spin labeling magnetic resonance imaging at 4 T and neuropsychological measures assessed absolute brain perfusion levels, cognition and selfregulation in 18 cigarette smoking opiate-dependent individuals (sODI) stable on buprenorphine maintenance therapy. The sODI were compared with 20 abstinent smoking alcohol-dependent individuals (a substance-dependent control group), 35 smoking controls and 29 nonsmoking controls. sODI had lower perfusion in several cortical and subcortical regions including regions within the brain reward/executive oversight system compared with smoking alcoholdependent individuals and nonsmoking controls. Perfusion was increased in anterior cingulate cortex and globus pallidus of sODI. Compared with all other groups, sODI had greater age-related declines in perfusion in most brain reward/executive oversight system and some other regions. In sODI, lower regional perfusion related to greater substance use, higher impulsivity and weaker visuospatial skills. Overall, sODI showed cortical and subcortical hypoperfusion and hyperperfusion. Relating to neuropsychological performance and substance use quantities, the frontal perfusion alterations are clinically relevant and constitute potential targets for pharmacological and cognitive-based therapeutic interventions to improve treatment outcome in opiate dependence.
INTRODUCTION
Opioid use disorders are a worldwide problem with enormous negative consequences to the individual and society in general (e.g. medical costs and loss of wages) (OCNNCC 2014; SAMHSA 2015) . Neuroimaging of opioid use disorders indicates altered brain structure (Lyoo et al. 2006; Liu et al. 2009; Yuan et al. 2009 ) and function (Forman et al. 2004; Yuan et al. 2010) . Effects on perfusion (i.e. cerebral blood flow) were mainly studied with nuclear medicine techniques, such as single-photon emission computed tomography (PET) imaging, revealing reduced perfusion primarily in anterior brain regions of opiate-dependent individuals (Pezawas et al. 2002; Botelho et al. 2006) and also inNoninvasive magnetic resonance imaging arterial spin labeling has been used to quantitate perfusion in alcohol, tobacco and stimulant use disorders (Gottschalk & Kosten 2002; Gazdzinski et al. 2006; Clark et al. 2007; Wang et al. 2007; Mon et al. 2009; Sullivan et al. 2013; Durazzo et al. 2015) , showing generally lower perfusion primarily in frontal cortex. Only one study in opiate-dependent individuals used arterial spin labeling and reported lower perfusion in frontal and parietal regions related to depression symptoms (Suh et al. 2009 ).
Cigarette smoking is prevalent among those with opiate use and substance use disorders (Pomerleau et al. 1997; Romberger & Grant 2004; . Co-morbid smoking and alcohol dependence were both independently associated with lower perfusion in frontal and parietal regions (Melgaard et al. 1990; Nicolas et al. 1993; Kuruoglu et al. 1996) ; perfusion reductions are clinically relevant as they are associated with greater smoking severity (Gazdzinski et al. 2006; Mon et al. 2009 ) and relapse to drinking within the first year after treatment (Durazzo et al. 2010) . Further, smoking polysubstance users had lower cortical and subcortical perfusion than smoking alcohol-dependent individuals (sALC) , highlighting perfusion differences between two smoking substance use disorder populations. Also, opiate-dependent individuals have higher impulsivity (Yucel et al. 2007; Xie et al. 2011; Qiu et al. 2013; Paydary et al. 2016; Tolomeo et al. 2016 ) and worse cognition, especially executive functions (Brand et al. 2008; Pluck et al. 2012) , although such research did not consider smoking status. Additional research in opiate dependence is warranted to explore the relationships of regional perfusion to cognition and measures of self-regulation such as impulsivity, decision making and risk taking, under the consideration of smoking status. Such information could help improve treatment approaches by tailoring treatments specifically to opiate-dependent individuals.
Early perfusion studies in substance dependence were limited by measurements obtained over large cortical gray matter regions and by not considering smoking status (smoker and nonsmoker) in the analyses. Here, we parcelated arterial spin labeling perfusion images into cortical and subcortical subregions and also analyzed the potential effects of smoking on regional perfusion. We focused on regions that are associated with the development and maintenance of addictive disorders (Makris et al. 2008; Haber & Knutson 2010) , largely localized to specific regions in frontal and mesial temporal lobes, limbic system and striatum. In this report, these regions are collectively referred to as the brain reward/executive oversight system (BREOS; (Durazzo et al. 2012; Durazzo et al. 2014; Murray et al., 2015) ), also termed the extended brain reward system (Durazzo et al. 2010; Cardenas et al. 2011; Durazzo et al. 2011; Kuceyeski et al. 2013) . Substance use disorders are associated with long-lasting plastic changes in neuronal and glial tissue of BREOS regions subserving 'top-down' inhibitory control/executive functions (Volkow et al. 2012) . Compromised integrity of BREOS components is linked to impaired regulation of striatum and limbic regions involved in the evaluation of reward, drive and emotional expression (George & Koob 2010) . Further, BREOS regions contain nodes that are part of the central executive network, salience network and reward network used in functional connectivity studies. Previous neuroimaging studies revealed multiple neurobiological abnormalities in BREOS regions in those with alcohol and substance use disorders (Meyerhoff 2014; Heitzeg et al. 2015) and associated with reward processing and motivation (George & Koob 2010) as well as deficits in executive functions, working memory, processing speed and visuospatial skills (Gazzaley & D'Esposito 2007) . Here, we compared chronically smoking opiatedependent individuals (sODI) on buprenorphine maintenance therapy with smoking controls (sCON) and with sALC, to place our findings in the context of a commonly studied treatment-seeking substancedependent group (Gazdzinski et al. 2006; Mon et al. 2009; Sullivan et al. 2013) . To help interpret potential smoking-related deficits in sODI, we also included a group of nonsmoking controls (nsCON) for comparison.
Specifically, we hypothesized that (1) sODI have lower perfusion in BREOS and parietal regions than either CON group, (2) sODI have greater regional perfusion alterations than sALC or sCON after controlling for smoking severity, (3) sODI have greater age-related declines in regional perfusion than other groups and (4) lower perfusion levels are associated with greater smoking severity and poorer neuropsychological performance.
MATERIALS AND METHODS

Participant characterization
All participants were fluent in English, provided written informed consents according to the Declaration of Helsinki and underwent procedures approved by the University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center. Eighteen sODI, stable on buprenorphine maintenance therapy for at least 3 months, met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for opiate dependence; they were allowed to meet DSM-IV criteria for current abuse or dependence on cocaine, amphetamines and/or cannabis, but dependence on alcohol or benzodiazepine was exclusionary. sODI were part of a local buprenorphine treatment program, and all studies were performed before smoking cessation. Twenty sALC, recruited from substance abuse treatment programs of the Veterans Affairs Medical Center and Kaiser Permanente, met DSM-IV criteria for alcohol dependence and were abstinent from alcohol for 14 ± 10 days (range 1-31) during the study. Thirty-five sCON and 29 nsCON were recruited from the community. All participants were studied with structural magnetic resonance imaging, arterial spin labeling perfusion and neuropsychological testing; they were allowed to smoke ad libitum before assessment and during breaks. Table 1 lists demographics, tobacco and alcohol use variables, as well as neuropsychological measures for the four groups.
Detailed exclusion criteria for sALC and CON were reported earlier ; participants in the current study were not included in the cohort. For all groups, participants were excluded for neurological disorders, psychiatric disorders and vascular risk factors known to affect neurobiology or cognition as well as for magnetic resonance imaging contraindications. In sODI and sALC, hepatitis C, type 2 diabetes, hypertension, unipolar mood disorder or generalized anxiety disorders were not exclusionary because of their high prevalence in addiction populations (Parekh & Klag 2001; Mertens et al. 2005; Stinson et al. 2005; Hasin et al. 2007) . Six sODI and two sALC had hepatitis C (by self-report and medical chart review), while two sODI, five sALC and two nsCON had medically controlled hypertension.
Psychiatric, medical and substance consumption assessment
The sODI and sALC completed the Structured Clinical Interview for DSM-IV Axis I disorders Patient Edition, v2.0 (First et al. 1998) , and modules assessing panic and posttraumatic stress disorder; CON completed the screening module. See for the details of our standard assessment protocol, which was used for the current sALC and CON groups; the cohort from our 2007 publication was not included in the current groups. None of the sALC had a Clinical Institute Withdrawal Assessment of Alcohol scale score of ≥8, which is indicative of clinically significant alcohol withdrawal symptoms; sALC were not in active withdrawal from alcohol. For all four groups, alcohol consumption was estimated with the lifetime drinking history interview (Skinner & Sheu 1982; Sobell et al. 1988) , nicotine dependence was assessed with the Fagerstrom Tolerance Test for Nicotine Dependence (Fagerstrom et al. 1991 ) and lifetime substance use history (other than alcohol) was assessed with a structured questionnaire (Pennington et al. 2015) . Participants also completed the Beck Depression Inventory (Beck 1978) and the State-Trait Anxiety Inventory (Spielberger et al. 1983) .
The sODI lifetime and recent substance use histories are given in Table 2 . All sODI were on supervised buprenorphine maintenance therapy for at least 3 months before study with an average dose of 15 ± 9 mg/day. Most sODI used stimulants and marijuana over lifetime, but few used these drugs within the last 30 days: one used opiates for 20 days, one used cocaine for 1 day, one used amphetamines daily and about one-third of the sample used marijuana recently (three used for 1 or 2 days, and three used for 30 days). The majority of sODI were alcohol drinkers (Table 1) , but none met criteria for an alcohol use disorder as it was exclusionary for buprenorphine treatment; only three consumed alcohol on >10 days within the last month prior to study. The sALC group was active cigarette smokers abstinent from alcohol for about 2 weeks, and few used other drugs within the last 30 days (three used marijuana; two used cocaine). Thus, both sODI and sALC groups were cigarette smoking treatment seekers, abstinent from their main drug of abuse for several weeks and had low levels of other recent substance use.
Neuropsychological performance and laboratory assessment
A standard neurocognitive battery was administered, Zscores were calculated based on corresponding normative data and cognitive domains were formed from specific neurocognitive tasks ). The cognitive domain scores in sALC, sCON and nsCON were calculated according to the neurocognitive battery of tests administered to the sODI group (details in Murray et al. (2016) ). Participants from all groups also completed self-regulation measures: the Barratt Impulsivity Scale (BIS-11; Patton et al. 1995) to assess self-reported impulsivity, the Balloon Analogue Risk Task (Lejuez et al. 2002) to assess risk taking and the Iowa Gambling Task (Bechara et al. 1994) to assess decision making. Laboratory tests within approximately 2 days of the scan evaluated the nutritional and hepatocellular status in all patient groups. See Table 1 for average cognitive domain and self-regulation measures for all groups.
Magnetic resonance data acquisition and processing
Magnetic resonance imaging was performed on a 4 T Bruker MedSpec system with a Siemens Trio console (Siemens, Erlangen, Germany) and an eight-channel Table 1 Demographics, tobacco and alcohol use variables, neuropsychological measures (cognition and self-regulation) and mood measures for all study groups (mean ± standard deviation). ) used a magnetization-prepared rapid gradient echo acquisition and the 2D axial T2-weighted sequence (0.9 × 0.9 × 3 mm 3 ) used a turbo-spin echo. Perfusion-weighted magnetic resonance imaging used a continuous arterial spin labeling single-shot echo-planar imaging sequence (Nezamzadeh et al. 2010; Tosun et al. 2012) , producing 16 oblique-axial 5-mm-thick slices oriented along the orbital-meatal line (in-plane resolution = 5 × 3.8 mm 2 , 1.22 mm slice gap, TR/TE = 5200/9 milliseconds repetition/echo time, 1.2 seconds labeling duration, 1590 milliseconds postlabeling delay, 90°flip angle, 6/8 partial Fourier encoding and 2894 Hz/pixel bandwidth). The bandwidth was optimized for echo-planar imaging to minimize geometrical distortions due to magnetic susceptibility effects. We acquired 40 control and 40 labeling scans, interleaved and averaged to boost the signal-to-noise ratio. Participants were instructed to remain awake with eyes closed during the 7-minute whole-brain perfusion sequence.
The main processing steps for each brain image volume outlined next are part of our in-house perfusion pipeline, including multiple manual quality control checks, as outlined in Figs 1 and 2 in Tosun et al. (2012) .
Briefly, an expectation maximization segmentation algorithm with correction for intensity inhomogeneity was applied to T1 images extracting the brain tissue from the skull and classified into fractions of white matter, gray matter and cerebrospinal fluid. Each individual skull-stripped and bias field-corrected image was motion-corrected and affine-registered to a reference image, an unbiased average brain generated from youngmiddle-aged healthy adults not included in the current dataset, using an unbiased atlas formation technique and then a non-linear inverse-consistent fluid-flow deformation spatially normalized each affine-registered individual brain to the reference brain (Lorenzen et al. 2005) . For each participant, the labeled and control images were rigidly (6 degrees of freedom) realigned to the first perfusion image acquired to correct for head positioning differences during scanning. The mean labeled and mean control images were computed; the resulting mean control image was subtracted from the mean labeled image, yielding raw perfusion-weighted image.
Then, the raw perfusion-weighted image was intensity normalized by the overall mean perfusion image (i.e. average of mean labeled and mean control images) and intensity scaled to obtain a measure equivalent to regional cerebral blood flow, and then the regional cerebral blood flow image was corrected for the tissue partial-volume effects. To accomplish this, both mean control perfusion image and regional cerebral blood flow volumes were first mapped onto the T2 structural image space using a multi-resolution affine registration algorithm based on normalized mutual information. We used a fluid-flow warping-based distortion correction algorithm, and the resulting non-linear deformation vector field was applied to the affine-registered regional cerebral blood flow image. The T2 image was rigidly aligned to the T1 image. The T2 to T1 rigid alignment transformation was applied to the non-linear geometric distortion-corrected regional cerebral blood flow image.
Regional cerebral blood flow images in T1 image space were corrected for partial-volume variations at each voxel, which is expressed in institutional rather than in absolute units of ml/100 mg/min, then mapped onto the reference brain image space by applying the participant's structural spatial normalization, then intensity calibrated. The resultant regional cerebral blood flow maps were filtered using a Gaussian smoothing kernel of 8 mm full-width-half-maximum in the reference brain image space. Regional cerebral blood flow images were aligned with FreeSurfer v5.1 parcelated labels (Fischl et al. 2002; Fischl et al. 2004 ) to yield participant-specific perfusion averages within predefined FreeSurfer regions, also part of our in-house pipelines. The inferior two to three slices from all perfusion datasets were removed before computation because of image distortions. FreeSurfer regions with at least 50 percent gray matter tissue were included in analyses. See Table 3 for regions forming the main regions of interest: BREOS, parietal, non-BREOS/non-parietal and subcortical. Left and right hemisphere perfusion values were averaged for bilateral regions after confirming the absence of significant laterality in almost all bilateral regions. From the current study, 2 percent of ALC and 47 percent of CON were included in a previous perfusion report of polysubstance use , and 92 percent of CON were used in a previous study comparing regional perfusion in chronic cigarette smokers with nonsmokers.
Statistical analyses
Main effects of group were tested by comparing the four groups (sODI, sALC, sCON and nsCON) on regional perfusion measures with the generalized linear model using maximum likelihood parameter estimation in SPSS v23 (IBM, Armonk, NY, USA). Age × group interactions were tested in the four-group model. Groups differed in the level of self-reported depression and anxiety symptomatologies, so that these variables were used as covariates in the generalized linear model, correlations and linear regressions. Significant main effects for group were followed up with pairwise group comparisons. Follow-up analyses investigated potential smoking severity effects in the three smoking groups. Total cigarettes/day and cigarette pack-years were separately employed as covariates because of group differences (Table 1) . Partial correlational analyses used Pearson product moment with age as covariate, and linear regression examined the associations of perfusion with self-regulation measures and cognition (individual tests were adjusted for age via appropriate norms).
For each a priori hypothesis (main effect and interactions), p < 0.05 was considered statistically significant. In group comparisons of perfusion levels without a specific a priori hypothesis, we conservatively adjusted alpha levels for all pairwise comparisons (corresponding to each generalized linear model for multiplicity), including correlations and linear regressions (unless a priori), with a modified Bonferroni procedure (Sankoh et al. 1997 ). This approach adjusts on the basis of the average intercorrelation of perfusion values across regions (or substance use and neuropsychological variables for correlations) in each analysis for all groups and the number of t-tests performed. The average intercorrelation for BREOS regions was r = 0.76, and the alpha level adjusted for eight tests was p ≤ 0.030. The corresponding values for parietal regions were r = 0.82, six tests, and p ≤ 0.036; for non-BREOS/non-parietal regions, r = 0.68, 10 tests, and p ≤ 0.024; for subcortical regions, r = 0.58, five tests, and p ≤ 0.025. The average intercorrelation for cognitive domains was r = 0.61, and the alpha level adjusted for six tests was p ≤ 0.025. The corresponding values for BIS were r = 0.71, four tests, and p ≤ 0.033; for drugs, r = 0.22, five tests, and p ≤ 0.014; for smoking severity, r = 0.57, four tests, and p ≤ 0.028; for alcohol severity, r = 0.38, three tests, and p ≤ 0.025. Effect sizes for mean regional perfusion level differences between groups were calculated as Cohen's d (Cohen 1988) .
RESULTS
Participant characteristics and neuropsychological function
As seen in Table 1 , the groups were matched on age. While the smoking groups (sODI, sCON and sALC) were not statistically different on years of smoking over lifetime or Fagerstrom Test for Nicotine Dependence score, sALC smoked more cigarettes/day and had greater pack-years than sCON (both p < 0.031). Further, the time between last cigarette and the scan differed between the three smoking groups (sODI versus sALC, sODI versus sCON and sCON versus sALC) and was used as a covariate. Not unexpectedly, lifetime drinking severity measures differed between groups. As shown in Table 1 , sODI had poorer executive functioning than sCON, as well as poorer cognitive efficiency, processing speed, visuospatial skills, working memory and global cognition than nsCON; sODI also had poorer working memory than both sCON and nsCON. Cognitive function was comparable between sODI and sALC. sODI had higher self-reported impulsivity than nsCON, but sODI were equivalent to the other smoking groups on all self-regulation measures. The four groups were not statistically different on measures of risk taking and decision making (Table 1 ).
In addition, those with medically controlled hypertension were not statistically different on any perfusion measure compared with those without hypertension. Furthermore, within each of the four groups, regional perfusion in those on a medication that could affect perfusion (antidepressant, anxiety, pain or thyroid medication) was not statistically different compared with the corresponding perfusion values in those not on medications; therefore, running the main generalized linear model without those on medications did not alter the main results conveyed here.
Regional perfusion by group
In the four-group model, significant main effects for group were observed in BREOS regions (insula, lateral and medial orbitofrontal cortex), the inferior parietal region, non-BREOS/non-parietal regions (frontal pole, hippocampus and superior temporal) and subcortical regions (globus pallidus, putamen and thalamus). A specific pattern emerged in sODI ( Fig. 1) : sODI demonstrated higher perfusion in globus pallidus compared with the other groups, higher rostral and caudal anterior cingulate cortex (ACC) perfusion than sCON and lower perfusion than both sALC and nsCON in insula, lateral orbitofrontal cortex, hippocampus and putamen. In addition, sODI had lower perfusion than nsCON in frontal pole, superior temporal cortex and caudate (also see Table 3 ).
Importantly, sODI demonstrated significantly greater age-related declines in perfusion than all other groups studied. sODI demonstrated significantly greater agerelated declines in perfusion than both nsCON and sCON in multiple BREOS regions (caudal and rostral middle frontal, medial orbitofrontal cortex, superior frontal, all p < 0.02) (Fig. 2 for age-related superior frontal perfusion changes across all four groups), parietal regions (isthmus cingulate, precuneus, posterior cingulate cortex, all p < 0.037) and non-BREOS/non-parietal regions (paracentral and precentral, both p < 0.02). Also, sODI had greater age-related declines in subcortical nuclei perfusion (accumbens area, caudate and putamen) than sCON (all p < 0.022) and greater age-related perfusion decline in the isthmus cingulate and thalamus than sALC (both p < 0.01). In addition, perfusion in 27 of the 29 subregions investigated did not differ by sex in the sODI group.
In follow-up pariwise group comparisons, sODI had lower perfusion than sALC in the insula, lateral orbitofrontal cortex, hippocampus and putamen (all p < 0.016). sODI demonstrated lower perfusion than nsCON in insula, lateral orbitofrontal cortex, frontal pole, hippocampus, superior temporal cortex, caudate, putamen, thalamus (all p < 0.02) and medial orbitofrontal cortex (p = 0.026). Most comparisons of regional perfusion between sODI and sCON were not significantly different. sCON had lower perfusion than nsCON in the medial and lateral orbitofrontal cortex, inferior parietal and superior temporal cortices, frontal pole, hippocampus, caudate, thalamus (all p < 0.013), isthmus cingulate and caudate (both p < 0.024). Including smoking measures or time between scan and last cigarette as covariates did not alter the pattern of perfusion differences in the three-group model (sODI, sCON and sALC); in linear regressions, smoking variables were not significant predictors in the model.
Association of perfusion with substance use measures
In sODI, higher amphetamine use in the past 30 days correlated significantly and negatively with insula and putamen perfusion (both r < À0.52, p < 0.01). Greater smoking severity was not associated with lower perfusion in sODI or sALC.
Although statistically significant before multiple comparison correction, the following correlations were only of moderate strength and need to be considered exploratory. In sODI, buprenorphine dosage correlated negatively with precuneus perfusion (r = À0.38, p = 0.027). In the past 30 days, heroin/opiate use in sODI correlated negatively with caudal ACC, insula, isthmus cingulate, posterior cingulate cortex and precuneus perfusion (all r < À0.41, p < 0.02), while years and amount of opiate use correlated negatively with precuneus, inferior parietal cortex and frontal pole perfusion (all r < À0.36, p < 0.032). Only in sCON was greater smoking severity negatively related with perfusion, as seen in lateral OFC, hippocampus, thalamus (all r < À0.40, p < 0.03), superior frontal, postcentral and precentral cortices (all r < À0.36, p < 0.04).
Association of perfusion with neuropsychological performance
In sODI, lower lateral orbitofrontal cortex perfusion was associated with worse visuospatial skills (r = 0.50, p = 0.025). In sALC, sCON and nsCON, higher regional perfusion did not correlate with better cognition. However, several negative correlations between perfusion and cognition in nsCON were apparent.
In sODI, lower perfusion in the caudate (r = À0.73, p = 0.001; Fig. 3 ) correlated with higher attentionimpulsivity and lower pars orbitalis perfusion correlated with higher motor-impulsivity (r = À0.61, p = 0.001). Further, in sODI, lower perfusion in dorsolateral prefrontal cortex components (caudal middle and superior frontal cortex; both r < À0.63, p < 0.001) and caudate (r = À0.68, p = 0.001) was associated with higher non-planning-impulsivity. In contrast to sODI, there were no such significant negative correlations between perfusion and impulsivity scores in sCON or nsCON, but a significant positive correlation emerged in nsCON. In nsCON (n = 18), perfusion in the medial orbitofrontal cortex correlated positively with nonplanning-impulsivity (r = 0.54, p = 0.02). The sALC group had too few participants with BIS-11 scores for meaningful assessment of correlations with regional perfusion. The regional perfusion levels did not relate significantly to the Balloon Analogue Risk Task and Iowa Gambling Task in any group.
Again, the following moderate-strength correlations should be considered exploratory and hypothesis generating and significant after multiple comparison correction. In sODI, lower perfusion in caudal ACC (r = À0.45, p = 0.015) correlated with higher attention-impulsivity. Further in sODI, lower perfusion in the rostral and caudal ACC, posterior cingulate cortex, inferior parietal, paracentral, pars opercularis, pars triangularis and postcentral cortex (all r < À0.49, p < 0.015) was associated with higher non-planningimpulsivity. In sCON (n = 30), lower perfusion in superior frontal, precuneus, paracentral, pars opercularis and caudate was associated with poorer visuospatial skills (all r > 0.42, p < 0.009). Also in sCON, perfusion in the caudal ACC, inferior and superior parietal, precuneus, cuneus, precentral and globus pallidus correlated positively with non-planning-impulsivity (all r > 0.42, p < 0.017).
DISCUSSION
This study compared regional brain perfusion levels, cognition and self-regulation measures among four groups: sODI on buprenorphine maintenance therapy, treatment-seeking sALC, sCON and nsCON. In many cortical regions and putamen and relative to nsCON, sODI had perfusion reductions similar to those detected in sCON, but unlike relatively normal perfusion levels observed in recently detoxified sALC. sODI also had regions of increased perfusion compared with the other groups (ACC and globus pallidus), potentially as a compensatory response to low perfusion in highly connected cortices. Also, with increasing age, cortical perfusion in multiple brain regions including BREOS showed steeper declines in sODI than in the other two substance using groups and nsCON. Lower perfusion in sODI related to a history of use (both amphetamines and heroin, but not tobacco), to lower visuospatial skills and to higher self-reported impulsivity. Collectively, our data demonstrate abnormal perfusion with neuropsychological correlates in sODI, which both may constitute new biomarkers of treatment response and specific targets for behavioral and pharmacological treatment of the majority of opioid addicts on buprenorphine therapy.
Previously, it had been unknown if perfusion in sODI declines with age, which, if present, would reinforce the value of early identification and treatment intervention of opiate dependence. Our results show that sODI had the steepest age-related perfusion declines of all four groups in many regions, including most BREOS regions. In our middle-aged sODI, significantly lower mean perfusion in the same regions as greater age-related perfusion declines than other substance using groups does not bode well for regional cerebral blood flow and their behavioral correlates in sODI of older age. This highlights the necessity for tailoring effective treatment to sODI, addressing perfusion and neuropsychological deficits as early as possible in life.
As predicted, sODI had lower perfusion than recently detoxified sALC in frontal and subcortical regions, despite similar smoking severities. These sODI also had greater metabolite concentration deficits than a 3-weekabstinent alcohol-dependent group with equivalent smoking severities as the current sALC group, notably in the ACC and the dorsolateral prefrontal cortex (Murray et al. 2016) . We showed previously that sCON had lower perfusion than nsCON ; because opioid dependence had been related to perfusion deficits, we hypothesized that individuals with chronic exposure to both opioids and tobacco would have lower perfusion than sCON. However, the differences between these groups were restricted to higher perfusion in the ACC and globus pallidus of sODI. Not surprisingly, sODI had lower regional perfusion than nsCON in many regions, consistent with previous reports that did not consider smoking status (Rose et al. 1996; Danos et al. 1998; Pezawas et al. 2002; Botelho et al. 2006) . Thus, the combination of opiate dependence and chronic smoking in sODI affected perfusion levels differently in selected regions of the BREOS and subcortex. Perfusion differences between sODI and sALC were not accounted for by differences in smoking levels, leaving it unclear if the combined effects of substance abuse and smoking on perfusion are specific to a certain substance.
The sODI had higher perfusion in the ACC and globus pallidus. We interpret this as a compensatory response to the lower perfusion in many other brain regions of sODI. Higher perfusion in frontal and/or globus pallidus with single PET or perfusion magnetic resonance imaging methods has been shown in cocaine and ecstasy users (Volkow et al. 1988; Reneman et al. 2001; Gottschalk & Kosten 2002) and in those with obsessive compulsive disease (Hugo et al. 1999) . Also, higher ACC perfusion in our sODI is consistent with a PET study that reported higher ACC glucose metabolism in opiate-dependent individuals compared with controls that was not related to maintenance therapy (Galynker et al. 2000) (but presumably related to opiate use). PET findings are relevant as cerebral perfusion is tightly coupled with glucose metabolism .
Basal ganglia and striatum have been identified as important targets for therapeutic and pharmacological interventions in substance addictions including opiate dependence, while pharmacotherapy effectiveness can be increased when combined with behavioral interventions (Konova et al. 2013) . To date, however, subcortical perfusion alterations have not been reported in heroin or opioid dependence; one study in cooccurring cocaine and heroin dependence reported perfusion deficits in the globus pallidus (Levin et al. 1995) , whereas another study of abstinent ecstasy users showed higher globus pallidus perfusion (Reneman et al. 2001) . We found both hyperperfusion and hypoperfusion in adjacent subcortical structures: higher globus pallidus perfusion and lower caudate and putamen perfusion only in sODI compared with sCON. In light of the overactive drive/reward processing in addiction in subcortical structures, we suspect that hypoperfusion in caudate and putamen in sODI may play a role in the higher impulsivity and poorer cognition observed in this population; this is supported by negative correlations of caudate perfusion with attention-impulsivity and with non-planning-impulsivity. As the globus pallidus is involved in motor learning and has been described to channel various types of information from the striatum via thalamus to frontal regions (Haber 2003; Draganski et al. 2008) , higher globus pallidus perfusion in sODI may be related to inefficiently conveying such information from hypoperfused striatal regions to (select) hypoperfused frontal regions (i.e. compensatory hyperperfusion in globus pallidus to offset hypoperfusion in connected regions). Imbalances in regional perfusion may be addressed pharmacologically in sODI, while cognitive-based therapeutic interventions may address their neuropsychological correlates.
Alternatively, it is possible that buprenorphine increased globus pallidus and ACC perfusion in sODI. All sODI were on buprenorphine maintenance therapy, which had previously been shown to improve parietal and occipital perfusion in co-morbid cocaine-dependent and heroin-dependent individuals in a dose-dependent manner (Levin et al. 1995) . Moreover, lower precuneus perfusion was related to buprenorphine therapy in our sODI; it is possible that higher buprenorphine therapy dose had an effect on precuneus perfusion because, in heroin users, greater urge to use opiates (lower buprenorphine dosage) related to lower precuneus perfusion (Sell et al. 2000) . Therefore, lower perfusion in many regions and higher perfusion in the ACC and globus pallidus along with altered self-regulation and cognition may be valuable biomarkers for treatment response in sODI.
Among sODI, lower perfusion, mainly in frontal but also in the insula and putamen regions, was associated with both the quantity and duration of illicit substance use (amphetamines and heroin) but not with cigarette smoking measures. We hypothesized that the combination of smoking and opiate dependence (as in the sODI group) would be associated with lower perfusion than seen in other smoking groups, because frontal perfusion is reduced in alcohol, tobacco and stimulant dependence; however, smoking severity measures were not related to perfusion in sODI, suggesting that illicit drug use may have had a stronger effect on perfusion levels than smoking in this sample of sODI. That said, it is also clear that cigarette smoking did have a negative effect on brain perfusion in sCON versus nsCON, unlike sODI and sALC, which is supported by prior research . Perfusion in parietal regions did not differ between smoking groups, which suggests that combined smoking and drug use (opiate or alcohol) affected parietal perfusion to similar degrees in sODI and sALC. Because smoking reduced perfusion in controls and given that our detoxified sALC did not show lower perfusion than nsCON (albeit 1-week-abstinent sALC had lower perfusion than nsALC (Gazdzinski et al. 2006) ), it is unclear if low perfusion in sODI (relative to a drug-free control group) is related to smoking or opioid use or perhaps both. Future studies that include a nonsmoking opiate-dependent group could address this question.
Our opiate-dependent individuals had impaired selfregulation compared with nsCON, consistent with previous research, which, however, had not accounted for smoking status. In sODI only, we found relationships between lower frontal (including dorsolateral prefrontal cortex) and caudate perfusion and higher values on all three impulsivity subscales; these associations and the higher than normal impulsivity in sODI are clinically relevant because impulsivity influences treatment response (Fineberg et al. 2010) . Similarly, meaningful associations between visuospatial skills and perfusion were observed only among sODI and sCON. Taken together, altered perfusion relates to clinically relevant behavioral measures of self-regulation and cognition, demonstrating their clinical utility. Conversely, the direction of significant relationships between perfusion and impulsivity in the nsCON group was unexpected and difficult to interpret.
This study had limitations: our sODI group was relatively small, too few women were enrolled to assess sex effects rigorously, caffeine intake prior to the scan that can potentially affect perfusion measures was not assessed and substance use measures were based on self-report. Also, sODI had a more extensive substance use history than sALC. Methodological limitations include that the perfusion sequence was optimized only for the cortex, that blood flow velocities (Gdovinova 2001; Terborg et al. 2002) or capillary transit times, both important for healthy tissue perfusion (Østergaard et al. 2013) , were not measured and that only one postlabeling delay was used, which did not address potential arterial transit time differences between tissue types, and may not have been equally sensitive to perfusion in all tissues and individual participants.
CONCLUSIONS
Our results demonstrate altered regional gray matter perfusion and self-regulation deficits were more pronounced in sODI than in the sALC or sCON groups. In sODI, the relationships of regional perfusion levels with altered neuropsychological performance suggest the necessity of addressing self-regulation and cognition, clinically relevant modifiable behaviors, during treatment. Because greater age-related regional perfusion declines were clearly evident in sODI compared with the other groups in many brain regions, early identification and treatment are especially important in this particular substance using group. Deficits in perfusion and selfregulation may constitute new biomarkers of treatment response. Therefore, future treatments for sODI could address perfusion deficits pharmacologically and explore cognitive-based therapeutic interventions to improve treatment outcome, preferably under proper consideration of the neurobiological and neuropsychological correlates of cigarette smoking and maintenance therapy.
